Skip to main content
Clinical Trials/NCT04957095
NCT04957095
Recruiting
Not Applicable

Motor Network Physiology Characterization During Deep Brain Stimulation Surgery

University of Texas Southwestern Medical Center1 site in 1 country120 target enrollmentFebruary 18, 2022

Overview

Phase
Not Applicable
Intervention
Apomorphine Injectable Solution
Conditions
Parkinson Disease
Sponsor
University of Texas Southwestern Medical Center
Enrollment
120
Locations
1
Primary Endpoint
cortical ECoG and subcortical recordings
Status
Recruiting
Last Updated
8 months ago

Overview

Brief Summary

The brain networks controlling movement are complex, involving multiple areas of the brain. Some neurological disorders, like Parkinson's disease (PD) and essential tremor (ET), cause abnormalities in these brain networks. Deep brain stimulation is a treatment that is used to treat these types of neurological diseases and is thought to help patients by modulating brain networks responsible for movement. Levodopa medication is also used to modulate this brain networks in patients with PD. The overall objective is to develop a unified theory of basal ganglia thalamocortical (BGTC) circuit dynamics that accounts for disease symptomatology, movement, and their inter-relationship. The underlying hypothesis, is that the rigidity and bradykinesia of PD are fundamentally related to excessive functional coupling across nodes in the BGTC motor circuit impeding effective information flow. In this research, the investigator will take advantage of the unique opportunity provided by awake deep brain stimulation surgery to learn more about how the brain functions in a diseased state and how deep brain stimulation changes these networks to make movement more normal. The investigator will simultaneously assess cortical and subcortical electrophysiology in relation to clinical symptoms and behavioral measures and in response to deep brain stimulation, cortical stimulation, and pharmacologic therapy in patients undergoing Deep Brain Stimulation (DBS) implantation surgery.

Registry
clinicaltrials.gov
Start Date
February 18, 2022
End Date
December 1, 2028
Last Updated
8 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nader Pouratian

Professor of Medicine

University of Texas Southwestern Medical Center

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Parkinson's disease who have been recommended to undergo deep brain stimulation for management of their movement disorder
  • Preoperative MRI without evidence of cortical or subdural adhesions or vascular abnormalities
  • Willingness and ability to cooperate during conscious operative procedure for up to 40 minutes

Exclusion Criteria

  • Patients with recent use (within one week) of anticoagulant or antiplatelet agents
  • Neurocognitive testing indicating amnestic cognitive deficits

Arms & Interventions

Parkinson's disease patients

This group consists of Parkinson's disease patients who are undergoing deep brain stimulation surgery for treatment of their movement disorder. Participants will complete behavioral assessments while receiving subcortical DBS stimulation and / or inhaled levodopa medication, Inbrija. Stimulation will be applied at the previously determined therapeutic frequency. Two capsules (84 mg) of Inbrija will be administered.

Intervention: Apomorphine Injectable Solution

Parkinson's disease patients

This group consists of Parkinson's disease patients who are undergoing deep brain stimulation surgery for treatment of their movement disorder. Participants will complete behavioral assessments while receiving subcortical DBS stimulation and / or inhaled levodopa medication, Inbrija. Stimulation will be applied at the previously determined therapeutic frequency. Two capsules (84 mg) of Inbrija will be administered.

Intervention: Subcortical Stimulation

Outcomes

Primary Outcomes

cortical ECoG and subcortical recordings

Time Frame: baseline

Cortical ECoG and subcortical LFP recordings will occur during DBS implantation surgery during the behavioral assessments and/or Inbrija administration.

Behavioral assessment

Time Frame: baseline

Each patient will complete a task that assesses the kinematics of movement, self-initiation of movement, and/or effect of Inbrija on movement

Study Sites (1)

Loading locations...

Similar Trials